First Header Logo Second Header Logo

Michael Goodman

Concepts (166)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Adenocarcinoma
10
2016
301
0.850
Why?
European Continental Ancestry Group
6
2017
1131
0.770
Why?
Colorectal Neoplasms
3
2017
208
0.750
Why?
Pancreatic Neoplasms
7
2016
131
0.700
Why?
African Americans
6
2017
1373
0.640
Why?
Colonoscopy
1
2017
41
0.590
Why?
Early Detection of Cancer
1
2017
75
0.570
Why?
Healthcare Disparities
2
2017
153
0.560
Why?
Lung Neoplasms
3
2017
387
0.520
Why?
Rural Health
1
2014
43
0.490
Why?
Common Bile Duct Neoplasms
4
2016
7
0.470
Why?
Ampulla of Vater
4
2016
7
0.470
Why?
Carcinoma, Non-Small-Cell Lung
1
2014
93
0.460
Why?
Oxidative Stress
1
2014
223
0.430
Why?
Adenocarcinoma, Mucinous
3
2017
20
0.400
Why?
Neoplasm Staging
7
2017
437
0.400
Why?
Appendiceal Neoplasms
3
2017
81
0.390
Why?
Carcinoma, Pancreatic Ductal
3
2016
19
0.360
Why?
Middle Aged
23
2018
10892
0.350
Why?
Aged
20
2018
9528
0.340
Why?
Bile Duct Neoplasms
2
2018
36
0.310
Why?
Mutation
3
2017
469
0.280
Why?
Humans
28
2018
29294
0.270
Why?
Carcinoid Tumor
2
2016
22
0.270
Why?
Carcinoma, Signet Ring Cell
2
2015
6
0.270
Why?
Male
22
2018
17896
0.270
Why?
Adult
17
2018
8484
0.270
Why?
Dermatology
2
2018
154
0.270
Why?
Female
21
2018
18270
0.260
Why?
Neuroendocrine Tumors
2
2015
20
0.250
Why?
DNA, Mitochondrial
2
2015
28
0.250
Why?
Neoplasm Invasiveness
5
2017
189
0.250
Why?
Proportional Hazards Models
6
2017
710
0.250
Why?
Aged, 80 and over
13
2018
3729
0.230
Why?
Retrospective Studies
9
2018
3129
0.230
Why?
Gallbladder Neoplasms
2
2012
33
0.220
Why?
Multivariate Analysis
4
2017
638
0.210
Why?
Survival Rate
8
2017
796
0.200
Why?
SEER Program
3
2017
33
0.200
Why?
Cytodiagnosis
2
2018
16
0.190
Why?
Bile Ducts
2
2018
18
0.190
Why?
Follow-Up Studies
5
2017
2117
0.190
Why?
Prognosis
7
2017
1366
0.170
Why?
DNA, Neoplasm
2
2017
58
0.160
Why?
Neoplasm Metastasis
2
2016
199
0.160
Why?
Specimen Handling
1
2017
31
0.150
Why?
Esophagectomy
1
2017
15
0.150
Why?
Colonic Polyps
1
2017
16
0.150
Why?
Pathology
1
2017
20
0.150
Why?
Neoplastic Cells, Circulating
1
2017
23
0.150
Why?
Incidence
2
2017
1123
0.150
Why?
Esophageal Neoplasms
1
2017
33
0.150
Why?
Sensitivity and Specificity
2
2018
533
0.150
Why?
Duodenal Neoplasms
1
2016
6
0.150
Why?
Epithelial Cells
1
2017
139
0.140
Why?
Comorbidity
2
2016
546
0.140
Why?
Prostatic Neoplasms
2
2015
442
0.140
Why?
Carcinoma, Squamous Cell
1
2017
142
0.140
Why?
Medicare
1
2017
188
0.130
Why?
Registries
1
2017
280
0.130
Why?
Analgesics
1
2016
126
0.130
Why?
Lymphoma, T-Cell, Cutaneous
1
2015
6
0.130
Why?
Electrons
1
2015
11
0.130
Why?
Mitotic Index
1
2014
2
0.130
Why?
Urinary Bladder Neoplasms
1
2017
179
0.130
Why?
Georgia
1
2014
13
0.130
Why?
Ki-67 Antigen
1
2014
29
0.130
Why?
Isoprostanes
1
2014
2
0.130
Why?
Bone and Bones
1
2015
88
0.130
Why?
beta Carotene
1
2014
5
0.130
Why?
Africa, Western
1
2014
4
0.120
Why?
Marital Status
1
2014
20
0.120
Why?
Carotenoids
1
2014
9
0.120
Why?
Gene Dosage
1
2014
34
0.120
Why?
Lymph Nodes
1
2015
92
0.120
Why?
Medical Records
1
2014
68
0.120
Why?
Social Class
1
2014
78
0.120
Why?
Age Distribution
1
2014
198
0.120
Why?
Bone Neoplasms
1
2015
104
0.120
Why?
Young Adult
5
2018
2415
0.110
Why?
Gallbladder
1
2012
2
0.110
Why?
Adenocarcinoma, Papillary
1
2012
3
0.110
Why?
Polyps
1
2012
8
0.110
Why?
United States
3
2017
3655
0.110
Why?
Skin Neoplasms
1
2015
206
0.110
Why?
Risk Factors
2
2017
3560
0.110
Why?
Adenoma
1
2012
35
0.110
Why?
Diet
1
2014
356
0.100
Why?
Cohort Studies
4
2017
1697
0.100
Why?
Immunohistochemistry
4
2016
520
0.100
Why?
Carcinoma in Situ
1
2010
13
0.100
Why?
Neoplasms
1
2017
620
0.100
Why?
Age Factors
4
2016
1115
0.090
Why?
Mucins
3
2016
19
0.090
Why?
Cross-Sectional Studies
1
2014
1371
0.090
Why?
Lymphatic Metastasis
3
2016
156
0.090
Why?
Disease Progression
3
2017
572
0.080
Why?
Diabetes Complications
1
2009
171
0.080
Why?
Observer Variation
2
2018
96
0.080
Why?
Sequence Analysis, DNA
2
2017
139
0.070
Why?
Treatment Outcome
4
2017
3116
0.070
Why?
Disease-Free Survival
2
2017
281
0.070
Why?
Survival Analysis
2
2017
440
0.060
Why?
Allelic Imbalance
1
2004
6
0.060
Why?
Chromosomes, Human, Pair 8
1
2004
13
0.060
Why?
Logistic Models
2
2017
729
0.060
Why?
Adolescent
3
2017
3267
0.060
Why?
Reproducibility of Results
2
2017
727
0.060
Why?
Neoplasm Recurrence, Local
1
2004
337
0.050
Why?
Predictive Value of Tests
2
2017
792
0.050
Why?
Pancreatic Ducts
1
2018
5
0.040
Why?
Appendectomy
1
2017
15
0.040
Why?
Prospective Studies
2
2016
2035
0.040
Why?
Colectomy
1
2017
25
0.040
Why?
Pathology, Molecular
1
2017
16
0.040
Why?
Genes, erbB-1
1
2017
15
0.040
Why?
Clone Cells
1
2017
36
0.040
Why?
Genes, Neoplasm
1
2017
18
0.040
Why?
Genes, p53
1
2017
23
0.040
Why?
Genes, ras
1
2017
26
0.040
Why?
Cholangiopancreatography, Endoscopic Retrograde
1
2017
31
0.040
Why?
Tumor Suppressor Protein p53
1
2017
71
0.040
Why?
Protein Kinase Inhibitors
1
2017
77
0.040
Why?
Chi-Square Distribution
1
2017
293
0.040
Why?
Diabetic Neuropathies
1
2016
23
0.040
Why?
Polymorphism, Single Nucleotide
2
2015
1079
0.040
Why?
Neoplastic Stem Cells
1
2017
90
0.040
Why?
Neoplasm Proteins
1
2017
141
0.030
Why?
Odds Ratio
1
2017
448
0.030
Why?
Gene Expression Profiling
1
2017
321
0.030
Why?
Drug Therapy, Combination
1
2016
273
0.030
Why?
Electron Transport Complex I
1
2015
3
0.030
Why?
Poisson Distribution
1
2015
15
0.030
Why?
Health Care Costs
1
2016
108
0.030
Why?
DNA Mutational Analysis
1
2015
67
0.030
Why?
Radiation Protection
1
2015
7
0.030
Why?
Mycosis Fungoides
1
2015
12
0.030
Why?
Mutation, Missense
1
2015
48
0.030
Why?
Base Sequence
1
2015
242
0.030
Why?
Molecular Sequence Data
1
2015
354
0.030
Why?
Radiotherapy
1
2015
75
0.030
Why?
Combined Modality Therapy
1
2015
525
0.030
Why?
Databases, Factual
1
2015
333
0.030
Why?
Sex Factors
1
2015
632
0.030
Why?
Smoking
1
2017
440
0.030
Why?
Phenotype
1
2015
631
0.030
Why?
Keratin-7
1
2012
1
0.030
Why?
Mucin-2
1
2012
1
0.030
Why?
Mucin-6
1
2012
1
0.030
Why?
Keratin-20
1
2012
6
0.030
Why?
Image Processing, Computer-Assisted
1
2014
242
0.030
Why?
Neoplasms, Multiple Primary
1
2012
20
0.030
Why?
Homeodomain Proteins
1
2012
50
0.030
Why?
Cell Lineage
1
2012
67
0.030
Why?
Gastrointestinal Neoplasms
1
2012
32
0.030
Why?
Antineoplastic Agents
1
2017
547
0.030
Why?
Risk Assessment
1
2017
1316
0.030
Why?
Pancreaticoduodenectomy
1
2010
21
0.020
Why?
Precancerous Conditions
1
2010
24
0.020
Why?
Cell Differentiation
1
2012
436
0.020
Why?
Preoperative Period
1
2009
32
0.020
Why?
Child
1
2015
2226
0.020
Why?
Breast Neoplasms
1
2015
673
0.020
Why?
Chromosomes, Human, Pair 18
1
2004
6
0.020
Why?
Polymerase Chain Reaction
1
2004
173
0.020
Why?
Prostatectomy
1
2004
79
0.010
Why?
Goodman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (166)
Explore
_
Co-Authors (18)
Explore
_
Similar People (52)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_